Gaspar António, Leite-Moreira Adelino F
Departamentos de Fisiologia e Cirurgia Cardio-Torácica, Unidade de Investigação e Desenvolvimento Cardiovascular da Faculdade de Medicina da Universidade do Porto e Hospital de S. João e Departamento de Cardiologia do Hospital de Braga, Portugal.
Rev Port Cir Cardiotorac Vasc. 2012 Oct-Dec;19(4):183-90.
Despite a significant improvement in the care of acute coronary disease, mortality and morbidity remain important. One explanation for this lies in the fact that the very coronary reperfusion may paradoxically result in additional myocardial injury, through the so-called ischemia-reperfusion injury, partially mitigating the beneficial effects of myocardial reperfusion. Over the past two decades, numerous pharmacological interventions (such as the use of antioxidants, anti-inflammatory, magnesium, glucose/insulin/potassium, rapid normalization of pH) were studied in order to prevent ischemia-reperfusion injury. Despite the promising results obtained in animal experiments, attempts to transpose these results to humans, and consequently to clinical practice, have been disappointing. On the other hand, cardiac ischemic conditioning is an intervention that has produced positive results. Ischemic conditioning refers to the protection induced by short periods of ischemia followed by reperfusion, prior to a major ischemic event. Ischemic stimulus can be applied before (pre-conditioning), during (per-conditioning) or after (post-conditioning) the major ischemic event. An important finding regarding cardiac ischemic conditioning, was that protection could be induced remotely, introducing the concept of remote ischemic conditioning. In this paper, we proposed to review the mechanisms underlying remote ischemic cardiac conditioning and the possible clinical applications, considering more specifically pre and per-conditioning.
尽管急性冠状动脉疾病的治疗有了显著改善,但死亡率和发病率仍然很高。对此的一种解释是,冠状动脉再灌注可能会通过所谓的缺血再灌注损伤,反常地导致额外的心肌损伤,部分抵消心肌再灌注的有益效果。在过去二十年中,人们研究了多种药物干预措施(如使用抗氧化剂、抗炎药、镁、葡萄糖/胰岛素/钾、快速纠正pH值)以预防缺血再灌注损伤。尽管在动物实验中取得了令人鼓舞的结果,但将这些结果应用于人类并进而应用于临床实践的尝试却令人失望。另一方面,心脏缺血预处理是一种产生了积极效果的干预措施。缺血预处理是指在重大缺血事件之前,由短暂的缺血后再灌注所诱导的保护作用。缺血刺激可以在重大缺血事件之前(预处理)、期间(围处理)或之后(后处理)施加。关于心脏缺血预处理的一个重要发现是,可以远程诱导保护作用,从而引入了远程缺血预处理的概念。在本文中,我们建议回顾远程缺血心脏预处理的潜在机制以及可能的临床应用,更具体地考虑预处理和围处理。